Tchaikapharma High Quality Medicines AD Logo

Tchaikapharma High Quality Medicines AD

Develops and manufactures generic and in-licensed pharmaceutical products.

THQM | BSOBGN

Overview

Corporate Details

ISIN(s):
BG1100008074
LEI:
5299003VDHTK75D1JE38
Country:
Bulgaria
Address:
бул./ул. бул. Г.М.ДИМИТРОВ № 1, 1172 София

Description

Tchaikapharma High Quality Medicines AD is a pharmaceutical company that develops and manufactures generic and in-licensed medicinal products. The company focuses on producing affordable, contemporary pharmaceuticals with a proven cost-effectiveness ratio to combat socially significant diseases. Its product portfolio targets a range of therapeutic areas, with a significant focus on cardiovascular conditions, including arterial hypertension, angina pectoris, and thrombosis. Other areas of specialization include treatments for cerebrovascular disease, Parkinson's disease, and metabolic syndrome, as well as anesthetics and anti-inflammatory drugs. The company is also a manufacturer of complex generics, such as polypills (fixed-dose combination medications).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-15 23:00
5299003VDHTK75D1JE38-20231231-BG-CON_CALCULATION-RES.html
English 47.8 KB
2024-04-15 23:00
609557-7TH_2023 CONS_BG_signed.xls
Bulgarian 719.5 KB
2024-04-15 23:00
609559-7TH_2023 CONS_EN_signed.xls
Bulgarian 235.0 KB
2024-04-15 23:00
609558-5299003VDHTK75D1JE38-20231231-EN-CON.zip
Bulgarian 6.4 MB
2024-03-26 23:00
608037-SPRAVKA_1_IND_GFO_6M.xls
Bulgarian 722.0 KB
2024-03-26 23:00
5299003VDHTK75D1JE38-20231231-BG-SEP.xhtml
Bulgarian 21.8 MB
2023-07-12 23:00
7TH_2022 CONS_BG.xls
Bulgarian 718.0 KB
2023-06-07 23:00
SPRAVKA_1_IND_GFO_6M_signed.xls
Bulgarian 778.5 KB
2023-06-07 23:00
5299003VDHTK75D1JE38-20221231-BG-SEP.xhtml
Bulgarian 37.0 MB
2022-07-26 23:00
5299003VDHTK75D1JE38-20211231-BG-SEP.xhtml
Bulgarian 5.7 MB
2022-07-26 23:00
7TH_2021_signed.xls
Bulgarian 939.0 KB
2022-07-26 23:00
5299003VDHTK75D1JE38-20211231-BG-CON.zip
Bulgarian 3.2 MB
2022-07-26 23:00
7TH_2021 CONS.xls
Bulgarian 900.0 KB

Automate Your Workflow. Get a real-time feed of all Tchaikapharma High Quality Medicines AD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Tchaikapharma High Quality Medicines AD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Tchaikapharma High Quality Medicines AD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.